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In cross-presentation, exogenous antigens taken up by 
APCs are processed for presentation by MHCI (Bevan, 
1976; Ackerman and Cresswell, 2004; Rock and Shen, 
2005). In vivo, cross-presentation of cell-associated anti-
gen has been attributed primarily to a subset of splenic 
DCs identified by expression of CD8α (den Haan 
et al., 2000). The dominant role of CD8α+ DCs in 
cross-presentation appears not to result from more ef-
ficient antigen capture but, rather, specialized pathways 
of processing that are active in CD8α+ DCs but not in 
CD8α− DCs (Schnorrer et al., 2006). CD8α+ DCs express cell- 
surface receptors, such as CLEC9A (Poulin et al., 2012), 
that can deliver antigens to cross-presentation pathways 
(Schulz and Reis e Sousa, 2002). Additionally, DC lyso-
somes have decreased protease activity, compared with 
macrophages, which improves antigen presentation and 
persistence in lymphoid organs (Delamarre et al., 2005). 
RAB27A (Jancic et al., 2007) and RAC2 (Savina et al., 
2009) have been linked to this process through recruit-
ment of NOX2 to phagosomes, which delays their acidifi-
cation by producing reactive oxygen species that consume 
protons generated by V-ATPase in phagosomal mem-
branes (Savina et al., 2006).
Peptides derived from exogenous proteins can be loaded 
onto MHCI either in the ER or in endocytic compartments 
where components of the peptide-loading complex have 
been recruited (Cebrian et al., 2011). Cross-presentation 
may involve movement of antigens from endosomes through 
transporters such as SEC61 into the cytosol where they are 
degraded (Zehner et al., 2015). Alternatively, cross-presenta-
tion may involve a strictly vacuolar pathway in which anti-
gens are digested by cathepsins within vesicles (Shen et al., 
2004) and directly loaded onto MHCI molecules that are 
present in the same compartment (Guermonprez et al., 2003). 
This pathway may be facilitated by the fusion of phagosomes 
with the ER–Golgi intermediate complex, a process enabled 
by SEC22B (Cebrian et al., 2011).
Much of the work done to identify these cross- 
presentation pathways has relied on in vitro generated 
monocyte-derived DCs (moDCs) and, therefore, not de-
scribed pathways that are unique to CD8α+ DCs in vivo 
(Cebrian et al., 2011; Nair-Gupta et al., 2014; Zehner et 
al., 2015). We identified RAB43 as a small GTPase that is 
specifically expressed in CD8α+ DCs and is necessary for 
optimal cross-presentation of cell-associated and soluble an-
tigens by CD8α+ classical DCs (cDCs) but not moDCs. We 
show that RAB43 is localized to the Golgi and cytoplasmic 
vesicles distinct from lysosomes and that it is not essential for 
normal Golgi development, in contrast to previous sugges-
tions (Haas et al., 2007).
In this study, to examine cross-presentation by classical dendritic cells (dcs; cdcs), we evaluated the role of rAB43, a protein 
found to be selectively expressed by Batf3-dependent cd8α+ and cd103+ compared with other dc subsets and immune lin-
eages. using a specific monoclonal antibody, we localized rAB43 expression to the Golgi apparatus and LAMP1− cytoplasmic 
vesicles. Mice with germline or conditional deletion of rab43 are viable and fertile and have normal development of cdcs but 
show a defect for in vivo and in vitro cross-presentation of cell-associated antigen. this defect is specific to cdcs, as rab43- 
deficient monocyte-derived dcs showed no defect in cross-presentation of cell-associated antigen. these results suggest that 
rAB43 provides a specialized activity used in cross-presentation selectively by cd8α+ dcs but not other antigen-presenting 
cells.
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resuLts And dIscussIon
rab43 is highly expressed in cd8α+ dcs
We evaluated expression of all RAB family members pres-
ent in mouse genome 430 2.0 microarrays (Satpathy et al., 
2012; Kc et al., 2014) for expression in CD8α+ DCs, CD8α− 
DCs, and common DC progenitors (CDPs; Fig. 1 A; Naik 
et al., 2007). Rab43 was among the most highly expressed 
RAB proteins in CD8α+ DCs compared with CDPs and 
CD8α− DCs. Mouse and human RAB43 are 95% identical 
(Fig. S1), suggesting evolutionary conservation. Using RT-
PCR, we directly confirmed that Rab43 was most highly 
expressed in CD8α+ DCs compared with CD8α− DCs, 
plasmacytoid DCs (pDCs), monocytes, T cells, and B cells 
(Fig. 1 B). In the skin-draining LN (sLN), CD8α+ resident 
and CD103+ migratory DCs express the highest levels of 
Rab43 (Fig. 1 C; Heng et al., 2008).
To analyze RAB43 at the protein level, we generated 
a monoclonal antibody, 2E6, directed to amino acids 179–
203, a region of RAB43 that is highly divergent from other 
RAB family members. Using 2E6 for Western analysis, we 
confirmed that RAB43 protein was specifically expressed in 
CD8α+ cDCs at levels that were substantially higher than in 
CD8α− DCs, pDCs, monocytes, T cells, and B cells (Fig. 1 D). 
Intracellular staining with biotinylated 2E6 also showed that 
RAB43 is most abundant in CD8α+ resident and CD103+ 
migratory DCs in the sLN compared with other DC subsets, 
similar to what is observed in the spleen (Fig. 1 E).
rab43-deficient mice are viable  
and have normal cdc development
RAB43 has only been examined by overexpression or shR-
NA-mediated knockdown in transformed cell lines in vitro 
(Haas et al., 2005, 2007; Fuchs et al., 2007). A potential 
dominant-negative RAB43 (T32N) mutation reportedly in-
duced Golgi fragmentation in HeLa cells (Haas et al., 2007), 
suggesting that RAB43 may function in Golgi development 
or maintenance. However, these conclusions were based on 
in vitro morphological analysis of HeLa and hTERT-RPE1 
cells, in which endogenous levels of RAB43 protein were 
not determined. No studies have yet analyzed the in vivo 
role of RAB43 or its function in CD8α+ DCs where it 
is most highly expressed.
To test the in vivo role of RAB43, we generated Rab-
43f/f mice that allow conditional deletion of the Rab43 exon 
2, which encodes critical residues of the Rab domain (Fig. 
S2). Conditional deletion in cDCs was achieved by crossing to 
CD11c (Itgax)-Cre (Caton et al., 2007) to produce Rab43cKO 
mice, and constitutive germline Rab43 deletion (Rab43Δ/Δ) 
was achieved on 129SvEv and C57BL/6 backgrounds by 
crossing to germline-expressing Cre-deleter strains.
Rab43Δ/Δ and Rab43cKO mice were viable and produced 
fertile offspring at normal Mendelian frequencies. To confirm 
that RAB43 protein was absent from DCs in Rab43Δ/Δ and 
Rab43cKO mice, we performed Western analysis for RAB43 
using 2E6 on CD11c− or CD11c+ splenocytes (Fig. 1 F). In 
WT mice, RAB43 protein was detected in CD11c+ spleno-
cytes but not in CD11c− splenocytes (Fig. 1 F), as expected. 
In Rab43Δ/Δ mice, RAB43 was not detectable in either 
CD11c+ splenocytes or CD11c− splenocytes, indicating that 
germline deletion of Rab43 exon 2 is sufficient to eliminate 
RAB43 protein (Fig. 1 F). In Rab43f/f mice, RAB43 was de-
tectable in CD11c+ splenocytes as expected, but RAB43 was 
nearly undetectable in Rab43cKO mice (Fig. 1 G). This result 
indicates that exon 2 deletion by CD11c-Cre can efficiently 
eliminate RAB43 protein in cDCs.
Loss of RAB43 in Rab43Δ/Δ mice caused no changes 
in the development of mature B cells, CD4+ T cells, CD8+ 
T cells, BM monocytes, or pDCs (not depicted). Furthermore, 
there was no impact on DC development in Rab43Δ/Δ 
mice, which showed normal populations of splenic cDCs 
(Fig. 1 H) and normal migratory and resident DCs in sLNs 
(Fig. 1 I). Populations of DCs were normal in nonlymphoid 
tissues such as the liver and small intestine lamina propria 
(Fig. 1 J). RAB43-deficient DCs also produced normal levels 
of cytokines upon stimulation by LPS, CpG, polyinosinic 
:polycytidylic acid (polyI:C), and soluble tachyzoite antigen 
(STAg; Fig.  1  K). Thus, RAB43 is selectively expressed in 
CD8α+ cDCs but is not required for their development 
or response to stimuli.
rAB43 is localized to the Golgi  
and LAMP1− vesicles in cd8α+ dcs
To determine the localization of RAB43 within DCs, we 
performed immunofluorescence microscopy on FLT3L- 
cultured BM cells using 2E6 antibody along with mark-
ers of various organelles (Fig.  2). RAB43 was expressed in 
brightly staining perinuclear organelles that colocalized with 
giantin, a cis-Golgi marker (Fig.  2, A and E). 2E6 staining 
was specific for RAB43 because no 2E6 signal was seen in 
Rab43Δ/Δ DCs (Fig. 2 A, bottom). RAB43 did not colocalize 
with the ER marker calnexin, (Fig. 2, B and E) and showed 
only limited colocalization with the trans-Golgi marker 
TGN38 (Fig. 2, C and E).
Specific RAB43 staining was also evident in small cyto-
plasmic vesicles throughout the DCs’ long dendritic branches 
(Fig. 2 F). No vesicular staining was seen in Rab43Δ/Δ DCs 
(Fig. 2 A). 2E6 staining did not colocalize with LAMP1, sug-
gesting that the RAB43-expressing vesicles are not lysosomes 
(Fig. 2, D and E). In summary, RAB43 appears to be expressed 
on cis-Golgi and in a nonlysosomal vesicular compartment.
rAB43-deficient cd8α+ dcs have an intact Golgi apparatus
Because RAB43 was suggested to control Golgi integrity in 
HeLa cells (Haas et al., 2007), we asked whether the Golgi 
was intact in DCs isolated from WT and Rab43Δ/Δ mice 
(Fig. 3, A and B). RAB43 colocalized with giantin in CD8α+ 
cDCs freshly isolated from WT mice (Fig. 3 A), in agreement 
with analysis of in vitro generated cDCs (Fig. 2). Freshly iso-
lated CD8α− cDCs were negative for 2E6 staining (Fig. 3 A), 
consistent with RAB43 expression assessed by Western anal-
o
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Figure 1. rab43is highly and selectively expressed in cd8α+ cdcs and does not impact cdc development. (A) Sorted WT CD8α+ DCs, CD8α− DCs, 
and BM CDPs analyzed by gene expression microarray. Expression levels were determined for a list of Rab proteins in mouse 430 2.0 and plotted based on 
CD8α+ DC/CDP (x axis) versus CD8α+ DC/CD8α− DC (y axis) expression ratios. Each dot indicates an individual probe set. Data are representative of at least 
two independent experiments with three pooled mice. (B) Expression value (in arbitrary units) of Rab43 mRNA normalized to Hprt by quantitative RT-PCR 
o
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ysis (Fig. 1 D) and intracellular staining (Fig. 1 E). The area 
of giantin staining is similar in both WT and Rab43Δ/Δ DCs, 
suggesting that the absence of RAB43 protein had no appar-
ent impact on its distribution (Fig. 3 C).
Furthermore, we used electron microscopy to exam-
ine CD8α+ DCs purified from Rab43f/f and Rab43cKO mice. 
There were no notable differences in morphology or density 
of Golgi membranes (Fig. 3, D and E). Glycoprotein analysis 
of LAMP1 shows that Golgi-mediated glycosylation is normal 
in Rab43Δ/Δ DCs (Fig. 3 F). It has also been shown that over-
expression of RN-tre, a possible GTPase-activating protein 
for RAB43 (Fuchs et al., 2007), does not alter ER to Golgi 
transport of vesicular stomatitis virus G in HeLa cells (Haas 
et al., 2007). Therefore, RAB43 appears to be dispensable for 
development and function of the Golgi apparatus in cDCs.
To analyze the localization of RAB43 after antigen up-
take, we incubated in vitro Flt3L-derived DCs with heat-killed 
Listeria monocytogenes expressing OVA (HKLM-OVA). We 
found that RAB43 still localizes to the Golgi after uptake of 
antigen and also that HKLM-OVA localized to a perinuclear 
region near the Golgi apparatus in both WT and Rab43Δ/Δ 
DCs (Fig. 3, G and H; and Videos 1 and 2). Therefore, RAB43 
localization is not dependent on the uptake of antigen.
A previous study has suggested that RAB43 is involved 
in the recruitment of cathepsin D to phagosomes (Seto et 
al., 2011). Because cathepsin D has been implicated in cross- 
presentation in human moDCs (Fonteneau et al., 2003), we 
examined whether the mechanism of RAB43 action could 
involve regulation of cathepsin D. We found that cathep-
sin D was not expressed in either cDC population at either 
the transcript or protein level and that this did not change 
upon activation by LPS (Fig.  3, I and J). This suggests that 
the mechanism of action of RAB43 in CD8α+ DCs does not 
involve the regulation of cathepsin D.
rAB43-deficient cd8α+ cdcs have reduced cross-
presentation both in vitro and in vivo
Because trafficking of intracellular vesicular compartments is 
necessary for antigen cross-presentation and CD8α+ DCs are 
efficient for this activity (den Haan et al., 2000; Iyoda et al., 
2002; Schnorrer et al., 2006; Hildner et al., 2008), we asked 
whether RAB43 might have a role in antigen presentation by 
DCs. CD8α+ DCs and CD8α− DCs purified from WT and 
Rab43Δ/Δ mice were tested for their ability to cross-present 
HKLM-OVA to OT-1 T cells in vitro (Fig. 4, A and B). WT 
CD8α+ DCs cross-presented HKLM-OVA in a dose-depen-
dent manner; however, CD8α+ DCs from Rab43Δ/Δ mice 
induced significantly less OT-1 proliferation at both low 
and high doses of bacteria (Fig. 4 A). Cross-presentation of 
HKLM-OVA by CD8α− DCs from WT or Rab43Δ/Δ mice 
was not observed at any dose tested (Fig. 4 B).
OT-1 T cells also proliferated in response to soluble 
antigen presented by WT CD8α+ DCs in a dose-dependent 
manner (Fig. 4 C). Using CD8α+ DCs from Rab43Δ/Δ mice, 
OT-1 proliferation was significantly reduced at intermediate 
doses of soluble OVA but not at the maximal dose (Fig. 4 C). 
CD8α− DCs were able to cross-present soluble OVA, but this 
required a higher concentration than that needed for OT-1 
stimulation by CD8α+ DCs, and there was no difference be-
tween WT and Rab43Δ/Δ DCs (Fig. 4 D). These results suggest 
that CD8α+ DCs have a unique cross-presentation program 
that is Rab43 dependent. This pathway is involved in the pre-
sentation of cell-associated but less so soluble antigens and 
may not be necessary for presentation of high soluble antigen 
loads. As a control, presentation of SII NFE KL peptide was 
equal between CD8α+ DCs and CD8α− cDCs from either 
WT or Rab43Δ/Δ mice, suggesting MHCI levels are normal 
on Rab43Δ/Δ DCs (Fig. 4 E).
We next tested the ability of Rab43cKO mice to prime 
T cells in vivo using cell-associated antigen (Carbone and 
Bevan, 1990). The number of active (CD44+CD62L−) Kb SII 
NFE KL tetramer-positive T cells in the spleen was analyzed 8 d 
after injection of irradiated MHCI TKO (Kb−/−Db−/−β2m−/−) 
splenocytes loaded with OVA or PBS. We found that Rab-
43cKO mice had a reduced ability to prime CD8 T cells against 
cell-associated antigen in vivo (Fig. 4 F).
The defect in T cell priming was specific to cross- 
presentation because direct presentation of intracellu-
for the indicated cell populations. Data from three independently sorted replicates of three WT mice displayed as mean ± SEM are shown. (C) Immgen data 
showing expression of Rab43 in the indicated populations from sLN. Data are displayed as mean ± SEM with three measurements per sample. (D) Western 
analysis of RAB43 and β-actin for the indicated spleen or BM populations from WT mice. Data are representative of at least three independent experiments. 
Mac, macrophage; Mono, monocyte. (E) Intracellular staining for RAB43 in the indicated cells from spleen and sLN from WT and Rab43Δ/Δ B6 mice. The 
numbers represent the mean fluorescence intensity of RAB43 staining for the indicated cells. Data are representative of two independent experiments. 
(F) Western analysis for RAB43 and lamin B from WT or Rab43Δ/Δ 129 (Δ/Δ) splenocytes. CD11c-negative (−) or CD11c-positive (+) splenocytes were iso-
lated using CD11c microbeads. Data are representative of at least two experiments. (G) Western analysis for RAB43 and lamin B from CD11c-negative (−) 
or CD11c-positive (+) B6 splenocytes isolated as in A derived from Rab43f/f mice that were either CD11cCre− (Cre-) or CD11cCre+ (Cre+) as indicated. Data 
are representative of at least two experiments. (D, F, and G) Scales indicate molecular weight in kD. (H) Percentage (left) and absolute number (right) of 
DC subpopulations from spleen of WT and Rab43Δ/Δ B6 mice. (I) Percentage (left) and absolute number (right) of DC subpopulations from sLN of WT and 
Rab43Δ/Δ mice. Cells gated based on resident (B220−MHC IIintCD11chi) and migratory (B220−MHC IIhiCD11cint/lo) populations are shown. (H and I) Data from 
three independent experiments are shown. Each dot represents a single mouse. (J) Contour plots of tissue DCs from the small intestine lamina propria 
(SILP) or liver of WT or Rab43Δ/Δ 129 mice pregated on B220−CD45.2+MHC II+CD11c+. Data are representative of at least two experiments. (K) Percentage of 
IL-12– and TNF-positive cells after incubation of FLT3L-cultured BM cells from WT and Rab43Δ/Δ 129 mice with LPS, CpG, polyI:C, or STAg. Data from two 
independent experiments displayed as mean ± SEM are shown.
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Figure 2. rAB43 is abundant in Golgi and vesicles of Batf3-dependent dcs. (A) Day 10 FLT3L-cultured BM from WT (top) or Rab43Δ/Δ (bottom) 129 
mice was treated with LPS for 4 h (to improve attachment), allowed to attach to coverslips, fixed, stained with 2E6 (anti-RAB43; green) and anti-giantin 
(red), and attached to slides using Prolong Gold antifade with DAPI (blue). (B–D) WT cells as described in A untreated with LPS were stained with 2E6 (green) 
and anti-calnexin (red; B), anti-TGN38 (red; C), or anti-LAMP1 (red; D). Coverslips were attached to slides using Prolong Gold antifade with DAPI (blue). 
(E) Percentage of organelle stain that is colocalized with RAB43 stain for the indicated organelles. Each dot represents a single cell with 10–23 cells analyzed 
per stain. Data were obtained using Imaris Coloc2. Statistics were analyzed using ANO VA. *, P < 0.05; ****, P < 0.0001. (F) WT cells prepared as described 
in A shown at increased zoom to highlight vesicular staining. All microscopy data are representative of at least two independent experiments. Bars, 5 µm.
o
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Figure 3. rab43Δ/Δcd8α+ dcs have normal Golgi development. (A and B) Sorted Ly6G−Ly6C−Thy1.2−B220−DX5−F4/80−CD11c+ splenocytes from WT (A) 
or Rab43Δ/Δ (Δ/Δ; B) 129 mice were allowed to attach to coverslips, fixed, and stained for CD8α (white), giantin (red), and RAB43 (green). Coverslips were 
attached to slides using ProLong Gold antifade with DAPI (blue). Data are representative of at least three independent experiments. Bars, 5 µm. (C) Area of 
Golgi staining from WT and Rab43Δ/Δ DCs. Each dot represents a single cell from staining in A and B, with 15 cells analyzed per genotype. Area was obtained 
using ImageJ. Statistics were analyzed by a two-tailed Mann-Whitney U test with P > 0.5. (D and E) Electron microscopy of sorted B220−CD11c+MHC II+-
CD24+CD172a− splenocytes from Rab43f/f-CD11cCre− (D) or Rab43f/f-CD11cCre+ (E) B6 mice showing normal Golgi development. Data are from analysis of cells 
from five pooled mice. Bars, 500 nm. (F) Western analysis for LAMP1 in splenocyte protein lysate given no treatment (No Tx), EndoH, or PNGaseF. Data are 
representative of three independent experiments. The scale indicates molecular weight in kD. (G and H) Sorted SiglecH−CD11b−Sirpa−Bst2− cells from FLT3 
cultures of WT (G) or Rab43Δ/Δ (H) B6 BM were incubated with Alexa Fluor 647–labeled HKLM-OVA (white) and then prepared as in B without CD8α stain 
(Videos 1 and 2). The yellow arrowhead indicates a RAB43-deficient DC that has taken up HKLM-OVA. Images are representative of three experiments. Bars, 
5 µm. (I) Immgen expression data for cathepsin D in red pulp macrophages (RP MF), CD8α+ DCs, and CD8α− DCs, displayed as mean ± SEM with three to 
four measurements per cell type. (J) Western analysis for cathepsin D (top) and β-actin (bottom) in BM macrophages (BMM), CD8α+ DCs, and CD8α− DCs 
from Flt3L or M-CSF cultures either treated or untreated with LPS for 24 h. The scale indicates molecular weight in kD.
o
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lar OVA and MHC II presentation were not affected in 
Rab43Δ/Δ mice (Fig.  4, G and H). In summary, RAB43 
functions in a cross-presentation–specific pathway that is in-
volved in the presentation of cell-associated and low-dose 
soluble antigen by CD8α+ DCs.
modcs from rAB43-deficient mice show no 
defect in cross-presentation
moDCs generated with GM-CSF and IL-4 can cross- 
present cell-associated antigen to a similar efficiency as CD8α+ 
DCs but use a distinct transcriptional program to acquire 
this capacity (Briseño et al., 2016). We asked whether cross- 
presentation by moDCs is Rab43 dependent (Fig. 5). Western 
analysis using 2E6 showed that RAB43 is expressed at a low 
level in moDCs generated with GM-CSF only (moDC GM) 
or with GM-CSF and IL-4 (moDC GM/4; Fig. 5 A). OT-1 
priming by Rab43Δ/Δ moDC GM/4 was equal to that of 
WT moDC GM/4 at all antigen doses for both presenta-
tion of OVA-loaded irradiated splenocytes and HKLM-OVA 
(Fig. 5, B and C). Thus, cross-presentation by moDCs uses 
a Rab43-independent pathway distinct from the Rab43- 
dependent pathway in CD8α+ DCs. Similarly, cross- 
presentation of soluble OVA by moDCs and cDCs can occur 
through distinct pathways (Segura et al., 2009).
Several in vitro studies have relied on moDCs cells to 
analyze cross-presentation (Cheong et al., 2010; Cebrian et 
al., 2011; Nair-Gupta et al., 2014; Zehner et al., 2015), even 
though in vivo cross-presentation appears specific to CD8α+ 
DCs (Iyoda et al., 2002; Schulz and Reis e Sousa, 2002; 
Sancho et al., 2009). Based on our data, moDCs may not be 
appropriate in vitro models for cross-presentation, and mol-
ecules analyzed using moDCs should be confirmed using 
primary CD8α+ DCs obtained from animal models.
In conclusion, RAB43 functions in a CD8α+ DC– 
specific pathway necessary for efficient cross-presentation of 
cell-associated antigen. Our data suggest that there are two 
separate pathways for soluble antigen presentation, and low-
dose presentation was seen only in CD8α+ DCs and was de-
pendent on RAB43. These results suggest that the form and 
amount of internalized antigen may impact how it is even-
tually processed and presented in CD8α+ DCs. This could 
be caused by differential endocytosis (i.e., receptor mediated 
versus micropinocytosis) or alternative methods of processing 
soluble proteins versus intact cells. The Golgi and vesicular 
localization of RAB43 suggests it may function in intracellu-
Figure 4. cd8α+ dcs from rab43Δ/Δ mice are defective in cross-pre-
sentation of cell-associated and soluble antigens. (A and B) Sorted 
CD8α+ (A) or CD8α− (B) DCs from WT (black) or Rab43Δ/Δ (red) B6 mice were 
cultured for 3 d with CFSE-labeled OT-I T cells and different doses of HKLM-
OVA and assayed for OT-I proliferation and activation (CFSE−CD44+). (C and 
D) Sorted CD8α+ (C) or CD8α− (D) DCs from WT (black) or Rab43Δ/Δ (red) 
mice were cultured and analyzed as in A with various doses of soluble OVA 
as antigen. (E) Sorted CD8α+ (continuous lines) or CD8α− (dashed lines) DCs 
from WT (black) or Rab43Δ/Δ (red) mice were cultured and analyzed as in 
A with the indicated amounts of SII NFE KL peptide as antigen. (F) Rab43f/f- 
CD11cCre− (black) or Rab43f/f-CD11cCre+ (red) mice were injected with the in-
dicated numbers of PBS (OVA−)- or OVA (OVA+)-loaded irradiated MHCI TKO 
splenocytes and analyzed 8 d later for the number of Kb SII NFE KL tetramer+ 
(tet+) T cells that were CD44+CD62L−. Each dot represents cells obtained 
from one mouse. (G) Sorted CD8α+ (solid) or CD8α− (dashed) DCs from WT 
(black) or Rab43Δ/Δ (red) mice were osmotically loaded with OVA, cultured, 
and analyzed as in A. (H) Sorted CD8α+ (solid) or CD8α− (dashed) DCs from 
WT (black) or Rab43Δ/Δ (red) mice were cultured for 3 d with CFSE-labeled 
OT-II T cells and irradiated splenocytes osmotically loaded with OVA. T cells 
were assayed for proliferation and activation (CFSE−CD44+). All data are 
displayed as mean ± SEM from at least two independent experiments. Sta-
tistics were analyzed using two-way ANO VA. ***, P < 0.001; ****, P < 0.0001.
o
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lar transport of antigen or the peptide-loading complex. Our 
data show that moDCs cross-present through mechanisms 
distinct from those used by CD8α+ DCs in vivo, suggest-
ing that previous mechanisms proposed for cross-presentation 
that relied on moDCs may need to be reevaluated in the 
correct cell type. These studies will provide useful insight 




WT 129SvEv mice were purchased from Taconic. WT 
C57BL/6, B6.SJL-PtprcaPepcb/BoyJ (B6.SJL), and 
C57BL/6-Tg(TcraTcrb)1100Mjb/J (OT-1) mice were pur-
chased from The Jackson Laboratory. Mice designated as 
WT were from in-house breeding of C57BL/6 or 129SvEv 
strains. Experiments done with Rab43f/f mice used littermate 
controls. MHCI KO mice (Kb−/−Db−/−β2m−/−; TKO) were 
a gift from H.W. Virgin and T. Hansen (Washington Univer-
sity, St. Louis, MO; Lybarger et al., 2003). Experiments were 
performed with age- and sex-matched mice between 6 and 
12 wk of age. All mice were bred and maintained in specific 
pathogen–free facilities according to institutional guideline 
protocols approved by the Animal Studies Committee of 
Washington University in St. Louis.
Generation of the rab43cKo mouse
The Rab43f/f-targeting construct was generated using Gateway 
recombination (Invitrogen) as follows. The entry vector, pENTR-
lox-FRT-rNeo, was created by replacing the puromycin resistance 
gene in pENTR-lox-Puro (Iiizumi et al., 2006) with the neomy-
cin resistance gene from vector pLNTK, and frt sites flanking each 
loxP site were added. The Rab43 5′ homology arm was amplified 
by PCR from 129SvEv-EDJ22 embryonic stem cell (ES cell) 
genomic DNA using oligonucleotides containing attB4 and attB1 
sites, 5′-GGG GAC AAC TTT GTA TAG AAA AGT TGG CAG 
ACC TCC TAC TCC AAAG-3′ and 5′-GGG GAC TGC TTT 
TTT GTA CAA ACT TGC AAG GCT GCA CTG AGG CTA-3′. 
 The attB4-attB1 PCR fragment was inserted into the pDONR 
(P4-P1R) plasmid (Invitrogen) by the bp recombination reac-
tion generating pENTR-RAB43-5HA. The Rab43 3′ homol-
ogy arm was amplified by PCR from genomic DNA using the 
following oligonucleotides containing attB2 and attB3 sites: 
5′-GGG GAC AGC TTT CTT GTA CAA AGT GGG AGC CAA 
TTC CTT ACC TCCA-3′ and 5′-GGG GAC AAC TTT GTA 
TAA TAA AGT TGT AGA AGG GAC GGA TGC AGC-3′. The 
attB2-attB3 PCR fragment was inserted into pDONR(P2R-P3) 
plasmid (Invitrogen) by the bp recombination reaction generating 
pENTR-RAB43-3HA. pENTR-RAB43-3HA was digested 
with Acc1 to produce an overhang where an overlapping oli-
gonucleotide containing an orphan loxP site could anneal. The 
annealed oligonucleotides for insertion of the orphan loxP site 
were as follows: 5′-CTA TAA CTT CGT ATA GCA TAC ATT ATA 
CGA AGT TAT GGA TCC-3′ and 5′-AGG GAT CCA TAA CTT 
CGT ATA ATG TAT GCT ATA CGA AGT TAT-3′. After ligation, 
sequencing confirmed the insertion of the orphan loxP, and the 
resulting plasmid was called pENT RE-RAB43-3HA-Acc1. LR 
recombination reaction was performed using pENTR-RAB43-
5HA, pENTR-RAB43-3HA-Acc1, pENTR-lox-FRT-rNeo, 
and pDEST-DTA-MLS to generate the final targeting construct.
Figure 5. modcs from rab43Δ/Δ mice show no defect in 
cross-presentation. (A) Western analysis of RAB43 and β-actin 
in CD8α+ and CD8α− cDCs compared with moDCs cultured for 4 
d with either GM-CSF alone (GM) or GM-CSF + IL-4 (GM/4). Data 
are representative of at least two experiments. The scale indicates 
molecular weight in kD. (B) GM-CSF + IL-4–cultured moDCs from 
WT (black) or Rab43Δ/Δ (red) 129 monocytes were cultured with 
the indicated numbers of PBS (OVA−)- or OVA (OVA+)-loaded irra-
diated MHCI TKO splenocytes and OT-I T cells. After 3 d, cultures 
were assayed for OT-I proliferation and activation (CFSE−CD44+). 
(C) Sorted CD8α+ and CD8α− DCs and in vitro generated moDC 
GM-CSF + IL-4 from WT (black) or Rab43Δ/Δ (red) B6 mice were 
cultured for 3 d with CFSE-labeled OT-I T cells and different doses 
of HKLM-OVA and assayed for OT-I proliferation and activation 
(CFSE−CD44+). Cross-presentation data are displayed as mean ± 
SEM from at least three independent experiments.
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The linearized vector was electroporated into EDJ22 
ES cells (129SvEv background), and targeted clones were 
identified by Southern analysis with the 5′ probe and con-
firmed with the 3′ probe. Probes were amplified from ge-
nomic DNA using the following primers: RAB43_5P_F, 
5′-GCC GAT GTC CTC AGA TCA AT-3′; RAB43_5P_R, 5′-
GTA GAG CCC TCG CTC CTT CT-3′; RAB43_3P_F, 5′-
GAA ACA GGT TGG AGC CCA TA-3′; and RAB43_3P_R, 
5′-TGA CTT GGA AAA GCC CAT TC-3′.
Blastocyst injections were performed to generate 
male chimeras. Germline Rab43+/fl mice were crossed to 
129S6-Tg(Prnp-GFP/Cre)1Blwd mice for constitutive 
germline deletion (RAB43Δ/Δ 129). Germline Rab43+/f 
were also crossed to B6.129S4-Gt(ROSA)26Sortm1(FLP1)
Dym/JRainJ (FLPeR) to delete the neomycin cassette, gen-
erating the Rab43fl allele. Rab43+/fl mice were backcrossed 
10 generations to the C57BL/6J background (stock no. 
029844). Rab43+/fl were either bred to B6.C-Tg(C-
MV-cre)1Cgn/J to generate Rab43Δ/Δ B6 mice (stock 
no. 029845) or bred to B6.Cg-Tg(Itgax-cre)1-1Reiz/J 
(CD11c-cre) mice from The Jackson Laboratory to gener-
ate conditional deletion of Rab43.
Genotyping PCR was conducted to confirm germline 
transmission and to confirm neo deletion from the FLPeR 
mouse. The primers used were the following: 5′-CAC TGC 
CCA GTC TAG CTT CC-3′, 5′-GAG TGG CTC TCC CCT 
TAA CC-3′, and 5′-GGG TGG GGT GGG ATT AGA TA-3′. 
To screen for the presence of the orphan loxP or constitutive 
deletion, we used the following primers: 5′-AGG CAG AAG 
CAA GCA GGT TT-3′, 5′-GTG ATC TGG GCC AAA ACG 
TA-3′, and 5′-CAA AGC TAT CCG ACC AGG AC-3′.
Antibodies and flow cytometry
Flow cytometry and cell-sorting experiments were com-
pleted on a FACS CantoII, FAC SAriaII, or FAC SAria Fusion 
instrument (BD) and analyzed using FlowJo analysis software 
(Tree Star). Staining was performed at 4°C in the presence of 
Fc block (clone 2.4G2; BD) in magnetic-activated cell-sort-
ing (MACS) buffer (Dulbecco’s PBS [DPBS] + 0.5% BSA 
+ 2 mm EDTA).The following antibodies were purchased 
from BD: anti-CD3 (145-2C11), anti-CD8 (53-6.7), an-
ti-CD11c (HL3), anti-CD19 (1D3), anti-B220 (RA3-6B2), 
anti-CD172a (P84), anti-Ly6C (AL-21), anti-Ly6G (1A8), 
and anti–H-2Kb (AF6-88.5). The following antibodies were 
purchased from BioLegend: anti-CD4 (RM4-5), anti-CD11c 
(N418), anti-CD24 (M1/69), anti-CD115 (AFS98), an-
ti-CD135 (A2F10), anti-MHC II (I-A/I-E; M5/114.15.2), 
and anti–TCR-Vα2 (B20.1). The following antibodies 
were purchased from eBioscience: anti-CD44 (IM7), an-
ti-CD45.2 (104), anti-CD90.2 (53-2.1), anti-CD103 (2E7), 
anti-CD117 (2B8), anti-CD317 (eBio927), anti-F4/80 
(BM8), anti-TER119 (TER-119), anti-CD62L (MEL-
14), and anti-SiglecH (eBio440c). The following antibod-
ies were purchased from Tonbo Biosciences: anti-CD11b 
(M1/70) and anti-CD45.1 (A20).
For immunofluorescence and confocal microscopy, 
the following antibodies were purchased from Abcam: rab-
bit polyclonal anti-giantin (ab24586) and rabbit polyclonal 
anti-calnexin (ab22595). The following antibody was pur-
chased from Santa Cruz Biotechnology, Inc.: rabbit poly-
clonal anti-TGN38 (sc-33784). The following antibodies 
were purchased from Invitrogen: Alexa Fluor 488 goat anti–
mouse IgG (H + L), Alexa Fluor 488 goat anti–rabbit IgG 
(H + L), Alexa Fluor 647 goat anti–rabbit IgG (H + L), and 
streptavidin, Alexa Fluor 555 conjugate.
For Western analysis, the following antibodies were pur-
chased from Santa Cruz Biotechnology, Inc.: anti–β-actin (C4) and 
anti–lamin B (M-20). Anti-Lamp1 (ab24170) was from Abcam. 
Anti–cathepsin D (AF1029) was from R & D Systems. H2-Kb 
SII NFE KL tetramer was purchased from MBL International.
dc preparation
To harvest DCs from lymphoid tissue, organs were minced 
and digested with 250 µg/ml collagenase B (Roche) and 30 
U/ml DNase I (Sigma-Aldrich) for 30–60 min at 37°C with 
stirring in 5  ml complete IMDM + 10% FCS (cIMDM). 
Erythrocytes (RBCs) were removed using ACK lysis buffer 
(150 mM ammonium chloride, 10 mM potassium bicarbon-
ate, and 0.1 mM EDTA). Cells were passed through a 70-µm 
nylon mesh and counted with a Vi-CELL analyzer (Beckman 
Coulter). For FACS analysis, 5–10 × 106 cells were stained in 
MACS buffer. Before sorting, DCs were first enriched using 
CD11c microbeads (Miltenyi Biotec).
For peripheral tissue DCs, organs were digested in colla-
genase D (Roche) and DNase I (Sigma-Aldrich) for 1 h at 37°C 
with stirring in 5 ml cIMDM. Liver cells were separated using 
a Percoll gradient (Sigma-Aldrich). Small intestine suspensions 
were prepared as described previously (Satpathy et al., 2013).
BM culture with FLt3L
BM was flushed from mouse tibias and femurs, and RBCs 
were removed using ACK lysis buffer. BM cells were cul-
tured at 2 × 106 cells/ml in cIMDM containing 100 
ng/ml FLT3L for 8–10 d. Loosely adherent cells were 
harvested for analysis.
modc preparation
To obtain BM monocytes, femurs, tibias, and hip bones were 
crushed using a mortar and pestle in MACS buffer. After pas-
sage through a 70-µm strainer, BM cells were isolated by gra-
dient centrifugation using Histopaque 1119 (Sigma-Aldrich). 
Before sorting, B cells were depleted using B220 microbeads 
(Miltenyi Biotec). Up to one million sorted monocytes were 
cultured in 3 ml cIMDM with 20 ng/ml GM-CSF with or 
without 20 ng/ml IL-4 (PeproTech) for 4 d. Loosely adherent 
cells were obtained for analysis.
cell sorting
Spleen DCs were sorted as B220−MHC II+CD11c+C-
D24+CD172− (CD8α+) and B220−MHC II+CD11c+ 
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CD24−CD172+ (CD8α−) DCs. Populations from BM were 
sorted as Lin− CD117intCD135+CD115+CD11c−MHC II− 
(CDP), B220+CD317+SiglecH+ (pDC), or MHC II−CD11c− 
SiglecH−B220−c-kit−Ly6G−M-CSFR+CD11b+Ly6chi (BM 
monocytes). Other populations were sorted from spleens as 
auto+ F4/80+ (macrophages), CD90.2+CD8+ (CD8 T cells), 
CD90.2+CD4+ (CD4 T cells), or B220+ (B cells). OT-1 cells were 
sorted as B220−CD4−CD11c−CD45.1+CD8+Vα2+. OT-II 
cells were sorted as B220−CD4+CD11c−CD45.1+CD8−Vα2+.
In vitro tLr stimulation
2 × 105 FLT3L-cultured BM cells were plated into 96-well 
plates and stimulated with the following TLR agonists: 1 µg/
ml LPS from Escherichia coli (055:B5; Sigma-Aldrich), 50 
µg/ml polyI:C (Sigma-Aldrich), 63 nM ODN1826, class 
B CpG oligonugleotide (CpG; InvivoGen), and 2.5 µg/ml 
STAg (prepared as previously described; Subauste, 2012). 
Cells were allowed to incubate at 37°C and 8% CO2 for 1 h, 
and then, 1 µg/ml brefeldin A was added for an additional 4 h. 
Cells were then washed and prepared for surface and intracel-
lular cytokine staining.
Antigen presentation assays
The in vivo cross-presentation assay has been previously de-
scribed (den Haan et al., 2000). In brief, for both in vivo and 
in vitro cross-presentation assays, MHCI TKO splenocytes 
were osmotically loaded with 10 mg/ml OVA (Worthing-
ton Biochemical Corporation), irradiated at 1,350 rad, and 
injected i.v. at the indicated doses. After 8 d, the spleens from 
the mice were harvested and analyzed for tetramer+ T cells.
For in vitro cell-associated antigen cross-presentation 
assays by moDCs, 25,000 CFSE-labeled OT-1 T cells were 
plated with 25,000 moDCs from WT or Rab43Δ/Δ 129 mice 
and various doses of MHCI TKO PBS- or OVA-loaded and 
irradiated splenocytes in cIMDM in a 96-well plate. After in-
cubating for 3 d in a 37°C and 8% CO2 incubator, CD45.1 
OT-1 T cells were analyzed by FACS analysis for CFSE dilu-
tion and up-regulation of CD44.
HKLM-OVA (a gift from H. Shen, University of Penn-
sylvania, Philadelphia, PA) was grown in Brain-Heart Infusion 
broth at 37°C for 6 h and then frozen overnight after dilution 
plating for titer enumeration. Then, bacteria was thawed and 
washed three times with DPBS before heat killing at 80°C for 
1 h and frozen at −80°C. 10,000 DCs from WT or Rab43Δ/Δ 
B6 mice were incubated with various doses of HKLM-OVA 
and 25,000 CFSE-labeled OT-1 T cells for 3 d in a 37°C 
5% CO2 incubator and assayed for CFSE dilution and CD44 
expression of OT-1 cells. Soluble OVA and peptide presenta-
tion assays used 10,000 DCs and 25,000 CFSE-labeled OT-1 
T cells for 3 d. In peptide presentation assays, DCs were in-
cubated with SII NFE KL for 45 min and then washed with 
cIMDM before incubation with 25,000 OT-1 T cells. Class 
II presentation assays were performed with 10,000 DCs in-
cubated with OVA-loaded irradiated splenocytes and sorted 
OT-II T cells for 3 d and then analyzed for OT-II prolifer-
ation. Direct presentation assays were performed by sorting 
DCs and performing hypertonic loading with soluble OVA 
protein (Worthington Biochemical Corporation). After load-
ing, 10,000 DCs were plated with 25,000 OT-1 cells for 3 d 
and then analyzed for OT-1 proliferation.
Generation of rAB43 monoclonal antibody
For immunization, we used Rab43−/− mice that were generated 
from Rab43tm1(KOMP)Wtsi ES cells (Knockout Mouse Project). 
Genotyping primers for Rab43−/− mice were: 5′-GCC ATC 
ACG AGA TTT CGA TT-3′, 5′-TCC CTT CCT ACA CAG 
CAT CC-3′, and 5′-CCT GGC TGA GCA CTA TGA CA-
3′. Rab43−/− mice were immunized with KLH-conjugated 
RAB43 peptide, KLH-CIM RHG GPM FSE KNT DHI QLD 
SKD IA (Genscript). Sera and hybridoma supernatants were 
screened by ELI SA using recombinant His-tagged RAB43 
produced as follows: Rab43 was amplified from cDNA using 
the primers RAB43 Nde1 F (5′-ATT AAG ATC TAT GGC 
GGG CCC TGG CC-3′) and RAB43 Xho1 R (5′-ATT ACT 
CGA GTC AGC ACC CAC AGC CCCA-3′) and cloned into 
the pET-28a+ vector (EMD Millipore). Recombinant protein 
was purified on Ni– nitrilotriacetic acid agarose (QIA GEN). 
Anti–mouse RAB43 antibody clone 2E6, an IgG1, was puri-
fied from hybridoma culture supernatant (Bio X Cell).
Intracellular staining
After staining for surface molecules, splenocytes were fixed 
in 4% paraformaldehyde in DPBS for 15 min at room tem-
perature, washed, and suspended in permeabilization buffer 
(DPBS + 0.5% saponin + 2% FCS). Cells were incubated 
with anti–mouse RAB43 antibody biotinylated using 
NHS-dPEG4-Biotin (G-Biosciences) for 30–60 min at 4°C, 
washed with DPBS buffer containing + 0.05% saponin + 2% 
FCS, and incubated with streptavidin-FITC (BD).
confocal microscopy
DCs from FLT3L-cultured BM were added to 24-well plates 
containing Alcian blue (Electron Microscopy Sciences)–
coated coverslips at 500,000 cells/well in cIMDM either 
alone or with 1 µg/ml LPS (Sigma-Aldrich) and allowed 
to adhere for 3–4 h at 37°C and 8% CO2. Cells were fixed 
in 4% paraformaldehyde (Electron Microscopy Sciences) 
in DPBS for 15 min at room temperature, quenched with 
0.4 M glycine in DPBS, washed, and incubated with Block-
Aid (Invitrogen) in 0.2% saponin. Cells were stained with 
primary antibody in 2% FCS and 0.2% saponin in DPBS 
overnight at 4°C. After washing 3 × 5 min in DPBS with 
0.2% saponin, cells were stained with secondary antibody in 
2% FCS and 0.2% saponin in DPBS for 1–2 h at 4°C. Cells 
were washed and mounted in ProLong Gold Antifade with 
DAPI (Invitrogen) and allowed to cure overnight at room 
temperature before imaging. FLT3L-cultured DCs were im-
aged using a confocal microscope (LSM-510; ZEI SS) with 
a 63× oil immersion objective and analyzed using ImageJ 
(National Institutes of Health).
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Labeled HKLM-OVA was prepared by labeling 3 × 
109 bacteria with 100 µl Alexa Fluor 647 succinimidyl ester 
(Thermo Fisher Scientific) for 1  h while vortexing. Then, 
bacteria were washed three times in PBS with reducing con-
centrations of BSA. HKLM-OVA was added to cells during 
attachment, and staining was performed as described in 
the previous paragraph.
Sorted Ly6G−CD90.2−B220−DX5−Ly6c−F4/80−CD11c+ 
splenocytes were plated at 100,000–300,000 cells/well in 
cIMDM onto anti-MHC II–coated coverslips in 24-well plates. 
After centrifuging at 1,000 rpm for 3 min, cells were allowed to 
adhere for 30–60 min at 37°C and 8% CO2, surface stained, and 
then fixed and stained similar to the FLT3L DCs.
Images of splenocytes and images after HKLM-OVA 
internalization were acquired on a confocal microscope 
(A1Rsi; Nikon) with a 60× oil immersion objective and an-
alyzed using ImageJ. Colocalization analysis was performed 
using ImarisColoc. In brief, fluorescence was masked on a 
cell-by-cell basis for organelle stain, and percentage of Rab43 
staining within that area was recorded. Golgi area was deter-
mined using ImageJ region of interest area calculations.
Western analysis
Isolated cells were washed in DPBS and resuspended in ra-
dioimmunoprecipitation assay lysis buffer with protease in-
hibitors at 107 cells/ml. Whole-cell extracts were obtained 
and denatured in Laemmli sample buffer at 95°C for 5 min. 
For glycosylation analysis, 2–3 × 106 cell equivalents of 
protein lysate were incubated with either EndoH Hf (New 
England Biolabs, Inc.) or PNGaseF (New England Biolabs, 
Inc.) for 1  h at 37°C as per the manufacturer’s protocol 
before Western analysis. 1 × 105–2.5 × 105 cell equivalents 
of whole-cell extract were run on a polyacrylamide gel and 
transferred onto a nitrocellulose membrane. Immunoblots 
were blocked in DPBS containing 3% BSA and 0.1% Tween 
20 at room temperature for 1 h and then incubated with 
primary antibody overnight at 4°C. After extensive wash-
ing, membranes were incubated with goat anti–rabbit IgG 
(H + L) or goat anti–mouse IgG (H + L) conjugated to 
horseradish peroxidase (Jackson ImmunoResearch Labora-
tories, Inc.) for 1 h at room temperature in 5% nonfat milk 
and 0.1% Tween 20 DPBS. Then, membranes were washed 
and developed with ECL Plus Western Blotting substrate 
(Thermo Fisher Scientific). Membranes were stripped using 
37.5 mM Tris-HCl, pH 6.8, 1% SDS, and 0.1 M β-mercap-
toethanol at 60°C for 30 min.
Quantitative rt-Pcr
Cells were processed using an RNeasy Mini kit (QIA GEN) 
and Superscript III reverse transcription (Invitrogen) fol-
lowing the manufacturer’s protocol to obtain RNA and 
subsequent cDNA. A StepOnePlus Real-Time PCR sys-
tem (Applied Biosystems) was used according to the man-
ufacturer’s instructions with the Quantitation-Standard 
Curve method and HotStart-IT SYBR green quantita-
tive PCR master mix (Affymetrix). PCR conditions were 
95°C for 10 min, followed by 40 two-step cycles of 95°C 
for 15  s and 60°C for 1 min. The primers used for mea-
surement of RAB43 were as follows: RAB43 quantitative 
PCR forward, 5′-ACT GGA TCG AGG ATG TGA GG-3′; 
and reverse, 5′-ACA TTG CTG GAG TCC TTT GC-3′. Hprt 
primers were as follows: HPRT quantitative PCR forward, 
5′-TCA GTC AAC GGG GGA CAT AAA-3′; and reverse, 
5′-GGG GCT GTA CTG CTT AAC CAG-3′.
Microarray analysis
Microarray data previously generated in our laboratory (GEO 
accession nos. GSE53312 and GSE37030; Satpathy et al., 
2012; Kc et al., 2014) or by the Immgen Consortium (GEO 
accession no. GSE15907; Heng et al., 2008) were analyzed. 
Gene array data were processed using robust multiarray av-
erage quantile normalization, and data were modeled using 
ArrayStar software (DNA STAR).
statistics
Statistical analyses were performed with Prism (GraphPad 
Software). Two-way ANO VA with multiple comparisons was 
performed for statistical significance.
online supplemental material
Fig. S1 shows a sequence alignment between human and 
mouse RAB43. Fig. S2 is the targeting strategy used to gen-
erate Rab43Δ/Δ and Rab43cKO mice. Video  1 shows a ro-
tating Z stack of a WT CD8α+ DC stained with RAB43, 
giantin, and DAPI after uptake of labeled HKLM-OVA. 
Video  2 shows a rotating Z stack of a Rab43Δ/Δ CD8α+ 
DC stained with RAB43, giantin, and DAPI after up-
take of labeled HKLM-OVA.
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Figure S1. sequence alignment of rAB43. (A) Sequence alignment for mouse RAB43 (mRAB43) and human RAB43 (hRAB43). Conserved sequence (*), 
conservative mutation (:), semiconservative mutation (.), and nonconservative mutation () are shown.
Figure S2. targeting strategy for rab43cKO. Shown are the Rab43 genomic locus, targeting vector, and mutated allele before removal of the neomycin 
cassette (pGK-Neo). Exons are displayed as boxes with coding regions shaded. An orphan LoxP sequence was inserted at the AccI site (A). Correctly targeted 
alleles show a 5.3-kB band detected by the 5′ probe and a 10-kB band detected by the 3′ probe. Chr., chromosome; DTA, diphtheria toxin A expression 
cassette; TK, thymidine kinase promoter. triangles, LoxP sequences; ovals, FRT sequences.
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Video 1. Localization of rAB43 after hKLM-oVA internalization. Rotating Z stack of sorted SiglecH−CD11b−Sirpa−Bst2− cells 
from FLT3 cultures of WT B6 BM were incubated with Alexa Fluor 647–labeled HKLM-OVA (white) and were allowed to attach 
to coverslips, fixed, and stained for giantin (red) and RAB43 (green). Coverslips were attached to slides using ProLong Gold an-
tifade with DAPI (blue).
Video 2. hKLM-oVA localization in rAB43-deficient dcs. Rotating Z stack of sorted SiglecH−CD11b−Sirpa−Bst2− cells from 
FLT3 cultures of Rab43Δ/Δ B6 BM were incubated with Alexa Fluor 647–labeled HKLM-OVA (white) and were allowed to attach 
to coverslips, fixed, and stained for giantin (red) and RAB43 (green). Coverslips were attached to slides using ProLong Gold an-
tifade with DAPI (blue).
